We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.26 | 6.34146341463 | 4.1 | 4.48 | 3.93 | 4871 | 4.12352139 | DE |
4 | -0.07 | -1.58013544018 | 4.43 | 4.6 | 3.75 | 7532 | 4.12976713 | DE |
12 | 0.4 | 10.101010101 | 3.96 | 4.6 | 3.75 | 8303 | 4.23306491 | DE |
26 | 0.73 | 20.1101928375 | 3.63 | 4.6 | 3.4 | 9153 | 4.00475174 | DE |
52 | 1.54 | 54.609929078 | 2.82 | 4.6 | 2.6 | 11880 | 3.58027194 | DE |
156 | 0.44 | 11.2244897959 | 3.92 | 4.6 | 2.15 | 10790 | 3.26481304 | DE |
260 | 0.66 | 17.8378378378 | 3.7 | 4.6 | 2.15 | 15312 | 3.49885701 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions